Corcept Therapeutics Incorporated (CORT) — Strategic Asset Allocation Index
Corcept Therapeutics Incorporated (CORT) has a Strategic Asset Allocation Index of 27.8% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $177.26 Million) total $177.26 Million, measured against net assets of $637.99 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Corcept Therapeutics Incorporated Strategic Asset Allocation Index (2003–2025)
This chart shows how Corcept Therapeutics Incorporated's Strategic Asset Allocation Index has evolved across 21 annual periods from 2003 to 2025. As of March 2026, the index stands at 27.8%, representing strategic assets of $177.26 Million against net assets of $637.99 Million USD. Explore cash efficiency ratio of Corcept Therapeutics Incorporated to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Corcept Therapeutics Incorporated (2003–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Corcept Therapeutics Incorporated from 2003 to 2025, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Corcept Therapeutics Incorporated worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 24.7% | $160.27 Million | $- | $160.27 Million | $647.80 Million | ▼ -7.6 pp |
| 2024 | 32.3% | $219.83 Million | $- | $219.83 Million | $679.59 Million | ▲ +21.1 pp |
| 2023 | 11.3% | $57.18 Million | $- | $57.18 Million | $506.70 Million | ▲ +9.9 pp |
| 2022 | 1.3% | $6.72 Million | $1.78 Million | $4.95 Million | $501.84 Million | ▼ -28.8 pp |
| 2021 | 30.1% | $113.28 Million | $1.00 Million | $112.28 Million | $375.81 Million | ▲ +22.9 pp |
| 2020 | 7.2% | $37.87 Million | $1.68 Million | $36.20 Million | $523.34 Million | ▼ -3.6 pp |
| 2019 | 10.9% | $40.40 Million | $1.05 Million | $39.35 Million | $371.18 Million | ▲ +10.6 pp |
| 2018 | 0.2% | $655.00K | $655.00K | $0.00 | $275.88 Million | ▼ -8.0 pp |
| 2017 | 8.3% | $15.80 Million | $518.00K | $15.28 Million | $190.97 Million | ▲ +7.8 pp |
| 2016 | 0.5% | $205.00K | $205.00K | $- | $41.38 Million | ▼ 0.0 pp |
| 2015 | 0.5% | $98.00K | $98.00K | $- | $18.50 Million | ▼ -0.4 pp |
| 2013 | 1.0% | $203.00K | $203.00K | $- | $21.02 Million | ▲ +0.7 pp |
| 2012 | 0.2% | $150.00K | $150.00K | $- | $61.78 Million | ▲ +0.2 pp |
| 2011 | 0.1% | $26.00K | $26.00K | $- | $34.81 Million | ▲ +0.1 pp |
| 2010 | 0.0% | $4.00K | $4.00K | $- | $21.24 Million | ▼ 0.0 pp |
| 2009 | 0.0% | $10.00K | $10.00K | $- | $22.09 Million | ▼ -0.1 pp |
| 2008 | 0.1% | $20.00K | $20.00K | $- | $16.91 Million | ▼ -0.1 pp |
| 2007 | 0.2% | $25.00K | $25.00K | $- | $14.73 Million | ▼ -0.4 pp |
| 2006 | 0.6% | $38.00K | $38.00K | $- | $6.36 Million | ▲ +0.4 pp |
| 2005 | 0.2% | $52.00K | $52.00K | $- | $26.59 Million | ▲ +0.2 pp |
| 2003 | 0.0% | $1.00K | $1.00K | $- | $10.24 Million | — |